121 related articles for article (PubMed ID: 12018996)
1. Influence of the a-ring on the proton affinity and anticancer properties of the prodigiosins.
Melvin MS; Tomlinson JT; Park G; Day CS; Saluta GR; Kucera GL; Manderville RA
Chem Res Toxicol; 2002 May; 15(5):734-41. PubMed ID: 12018996
[TBL] [Abstract][Full Text] [Related]
2. Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products.
La JQ; Michaelides AA; Manderville RA
J Phys Chem B; 2007 Oct; 111(40):11803-11. PubMed ID: 17867672
[TBL] [Abstract][Full Text] [Related]
3. Influence of the a-ring on the redox and nuclease properties of the prodigiosins: importance of the bipyrrole moiety in oxidative DNA cleavage.
Melvin MS; Calcutt MW; Noftle RE; Manderville RA
Chem Res Toxicol; 2002 May; 15(5):742-8. PubMed ID: 12018997
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
Manderville RA
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
[TBL] [Abstract][Full Text] [Related]
5. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue.
Tomlinson JT; Park G; Misenheimer JA; Kucera GL; Hesp K; Manderville RA
Org Lett; 2006 Oct; 8(21):4951-4. PubMed ID: 17020344
[TBL] [Abstract][Full Text] [Related]
6. The prodigiosins: a new family of anticancer drugs.
Montaner B; Pérez-Tomás R
Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
[TBL] [Abstract][Full Text] [Related]
7. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.
Ohkuma S; Sato T; Okamoto M; Matsuya H; Arai K; Kataoka T; Nagai K; Wasserman HH
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):731-41. PubMed ID: 9729483
[TBL] [Abstract][Full Text] [Related]
8. Influence of B-ring modifications on proton affinity, transmembrane anion transport and anti-cancer properties of synthetic prodigiosenes.
Marchal E; Rastogi S; Thompson A; Davis JT
Org Biomol Chem; 2014 Oct; 12(38):7515-22. PubMed ID: 25204645
[TBL] [Abstract][Full Text] [Related]
9. Prodigiosins as a new group of H+/Cl- symporters that uncouple proton translocators.
Sato T; Konno H; Tanaka Y; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
J Biol Chem; 1998 Aug; 273(34):21455-62. PubMed ID: 9705273
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-cancer activity of C-ring-functionalized prodigiosin analogues.
Regourd J; Ali AA; Thompson A
J Med Chem; 2007 Apr; 50(7):1528-36. PubMed ID: 17348639
[TBL] [Abstract][Full Text] [Related]
11. Synthetic prodigiosenes and the influence of C-ring substitution on DNA cleavage, transmembrane chloride transport and basicity.
Rastogi S; Marchal E; Uddin I; Groves B; Colpitts J; McFarland SA; Davis JT; Thompson A
Org Biomol Chem; 2013 Jun; 11(23):3834-45. PubMed ID: 23640568
[TBL] [Abstract][Full Text] [Related]
12. New insights on the antitumoral properties of prodiginines.
Pérez-Tomás R; Viñas M
Curr Med Chem; 2010; 17(21):2222-31. PubMed ID: 20459382
[TBL] [Abstract][Full Text] [Related]
13. Anion transporters and biological systems.
Gale PA; Pérez-Tomás R; Quesada R
Acc Chem Res; 2013 Dec; 46(12):2801-13. PubMed ID: 23551251
[TBL] [Abstract][Full Text] [Related]
14. DNA Binding by 4-Methoxypyrrolic Natural Products. Preference for Intercalation at AT Sites by Tambjamine E and Prodigiosin.
Melvin MS; Ferguson DC; Lindquist N; Manderville RA
J Org Chem; 1999 Sep; 64(18):6861-6869. PubMed ID: 11674696
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of nonylprodigiosin and macrocyclic prodigiosin analogues.
Fürstner A; Grabowski J; Lehmann CW; Kataoka T; Nagai K
Chembiochem; 2001 Jan; 2(1):60-8. PubMed ID: 11828428
[TBL] [Abstract][Full Text] [Related]
16. Prodigiosins as anti cancer agents: living upto their name.
Pandey R; Chander R; Sainis KB
Curr Pharm Des; 2009; 15(7):732-41. PubMed ID: 19275639
[TBL] [Abstract][Full Text] [Related]
17. Prodigiosin 25-C and metacycloprodigiosin suppress the bone resorption by osteoclasts.
Woo JT; Ohba Y; Tagami K; Sumitani K; Kataoka T; Nagai K
Biosci Biotechnol Biochem; 1997 Feb; 61(2):400-2. PubMed ID: 9058987
[TBL] [Abstract][Full Text] [Related]
18. Equilibrium and kinetics of rotamer interconversion in immunosuppressant prodigiosin derivatives in solution.
Rizzo V; Morelli A; Pinciroli V; Sciangula D; D'Alessio R
J Pharm Sci; 1999 Jan; 88(1):73-8. PubMed ID: 9874705
[TBL] [Abstract][Full Text] [Related]
19. Indoloprodigiosins from the C-10 bipyrrolic precursor: new antiproliferative prodigiosin analogs.
Baldino CM; Parr J; Wilson CJ; Ng SC; Yohannes D; Wasserman HH
Bioorg Med Chem Lett; 2006 Feb; 16(3):701-4. PubMed ID: 16289814
[TBL] [Abstract][Full Text] [Related]
20. A prodigiosin from the roseophilin producer Streptomyces griseoviridis.
Kawasaki T; Sakurai F; Hayakawa Y
J Nat Prod; 2008 Jul; 71(7):1265-7. PubMed ID: 18553921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
